Assessing the future of diffuse optical imaging technologies for breast cancer management

Beckman Laser Institute and Medical Clinic, University of California Irvine, Irvine, California 92612, USA.
Medical Physics (Impact Factor: 3.01). 06/2008; 35(6):2443-51. DOI: 10.1118/1.2919078
Source: PubMed

ABSTRACT Diffuse optical imaging (DOI) is a noninvasive optical technique that employs near-infrared (NIR) light to quantitatively characterize the optical properties of thick tissues. Although NIR methods were first applied to breast transillumination (also called diaphanography) nearly 80 years ago, quantitative DOI methods employing time- or frequency-domain photon migration technologies have only recently been used for breast imaging (i.e., since the mid-1990s). In this review, the state of the art in DOI for breast cancer is outlined and a multi-institutional Network for Translational Research in Optical Imaging (NTROI) is described, which has been formed by the National Cancer Institute to advance diffuse optical spectroscopy and imaging (DOSI) for the purpose of improving breast cancer detection and clinical management. DOSI employs broadband technology both in near-infrared spectral and temporal signal domains in order to separate absorption from scattering and quantify uptake of multiple molecular probes based on absorption or fluorescence contrast. Additional dimensionality in the data is provided by integrating and co-registering the functional information of DOSI with x-ray mammography and magnetic resonance imaging (MRI), which provide structural information or vascular flow information, respectively. Factors affecting DOSI performance, such as intrinsic and extrinsic contrast mechanisms, quantitation of biochemical components, image formation/visualization, and multimodality co-registration are under investigation in the ongoing research NTROI sites. One of the goals is to develop standardized DOSI platforms that can be used as stand-alone devices or in conjunction with MRI, mammography, or ultrasound. This broad-based, multidisciplinary effort is expected to provide new insight regarding the origins of breast disease and practical approaches for addressing several key challenges in breast cancer, including: Detecting disease in mammographically dense tissue, distinguishing between malignant and benign lesions, and understanding the impact of neoadjuvant chemotherapies.

Download full-text


Available from: Albert Cerussi, Sep 04, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The implementation of hybrid fluorescence molecular tomography (FMT) and X-ray computed tomography (CT) has been shown to be a necessary development, not only for combining anatomical with functional and molecular contrast, but also for generating optical images of high fidelity and quantification accuracy. FMT affords highly sensitive three-dimensional imaging of fluorescence bio-distribution throughout animal bodies but in stand-alone form it offers images of low resolution. It was shown that FMT accuracy significantly improves by considering anatomical priors from X-ray computed tomography (CT). Conversely, X-ray CT generally suffers from low soft tissue contrast. Therefore utilization of X-ray CT data as prior information to the fluorescence inversion problem is challenging in applications where different internal organs are not clearly differentiated. Instead, we combined herein FMT with emerging X-ray phase-contrast computed tomography (PCCT). PCCT relies on the phase shift differences in tissue to deliver anatomical images of biological samples with superior soft tissue contrast than conventional absorption-based CT. We demonstrate for the first time hybrid FMT-PCCT imaging of different animal models, where FMT and PCCT scans were performed in vivo and ex vivo, respectively. The results show that FMT-PCCT expands the potential and utility of FMT in imaging lesions which show otherwise low or no contrast in conventional CT, while retaining the cost benefits and technical simplicity of CT and single hybrid devices. The results point to the most accurate hybrid FMT performance to date.
    IEEE Transactions on Medical Imaging 03/2014; 33(7). DOI:10.1109/TMI.2014.2313405 · 3.80 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Acoustic lenses made of acrylic plastic (PMMA) have been used to enlarge the acceptance angle of sensitive large surface area detectors and improve lateral resolution. However, PMMA lenses introduce image artifacts due to ultrasound internal reflections within the lenses. In this work we investigated this issue proposing a new lens material Stycast 1090SI. We characterized the acoustic properties of the proposed material in comparison with PMMA. Detector performance using negative lenses with the two materials, was tested using finite element simulation and experiment. Further the image quality of a photoacoustic tomography system was studied using k-Wave simulation and experiment. Our acoustic characterization showed that Stycast 1090SI has tissue-like acoustic impedance, high speed of sound and low acoustic attenuation. Both acoustic lenses show significant enlargement of detector acceptance angle and lateral resolution improvement. However, image artifacts induced by acoustic lenses are reduced using the proposed lens compared to PMMA lens.
    05/2013; 1(2). DOI:10.1016/j.pacs.2013.05.001
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Diffuse optical imaging (DOI) techniques provide a non-invasive, low cost and sensitive method for assessing the functional state of the human breast. Several studies undertaken in recent years with the objective of investigating the clinical applications of diffuse optical methods, demonstrate the potential of the technique for screening for breast cancer, associated risk factors and for monitoring the efficacy of therapeutic regimen post-diagnosis. In this review, the different diffuse optical methods and instrumentation used in the functional imaging of the breast are described and the results of the clinical studies of the healthy and diseased breast are provided. Moreover, the application of optical imaging in moni-toring neo-adjuvant chemotherapy is summarized, the role of alternate contrast mechanisms in optical imaging is outlined and lastly, the role of optical imaging in multimodal imaging – wherein optical imaging is combined with existing clinical imaging modalities providing complementary diagnostic information – is discussed.
    Current Medical Imaging Reviews 08/2012; 8(3):244-259. DOI:10.2174/157340512803759884 · 1.06 Impact Factor